10.05.2021
Primary brain cells on Qube 384
10.05.2021
Developing a stable high-throughput assay using electroporation transfected cells
10.10.2019
Stable Vhalf values and reliable potentiation of Kv7.3/7.2 currents on Qube 384
02.10.2019
QPatchを用いたNaV1.5 (late) 電流 心臓安全性評価試験
26.09.2019
Electrophysiological characterization of human iPSC-derived motor neurons using Qube 384 and QPatch
24.09.2019
Nav1.5(Late) cardiac safety assay on QPatch
31.07.2019
Perforated patch clamp recordings on Qube 384
16.05.2019
8 hours unattended hERG run with ≥97% success rate and consistent pharmacology results
10.04.2019
VHalf adaptive protocols on Qube
26.03.2019
Pharmacological evaluation of GABAA receptor subtypes on Qube 384
09.01.2019
Cav1.2 on Qube 384 – pharmacology, stability and CiPA
13.11.2018
QPatchにおけるCiPA Milnes hERG動態アッセイ
27.09.2018
QPatchにおけるCiPA Milnes hERG動態アッセイ
01.02.2018
Nav1.1 currents on Qube
30.01.2018
Human iPS cell-derived cardiomyocytes on Qube 384
15.01.2018
hCav1.2 recordings on Qube 384 using step, train and CiPA protocols
11.12.2017
Cell culturing for automated patch clamp
02.11.2017
Reliable Kv2.1 assasy and pharmacology on the QPatch
27.10.2017
Fast desensitizing ion channels recorded on Qube 384
05.10.2017
High throughput screening for mode-of-action on Nav1.4
22.08.2017
CHO-hERG DUO optimized for QPatch
29.06.2017
Temperature control on Qube 384 – pharmacological dependency of hERG reference compounds
08.05.2017
Internal solution exchange on Qube
05.04.2017
HEK-Cav3.2 recordings on QPatch
04.04.2017
CHO-Nav1.5 on QPatch
04.04.2017
Cor.4U on QPatch
04.04.2017
GH4-C1 nAChR a7 on QPatch
04.04.2017
HEK293-Cav2.2 on QPatch
31.03.2017
NIH 3T3 CFTR on QPatch
31.03.2017
Stable response for ligand and voltage-gated ion channels on QPatch
31.03.2017
RD(TE671)-nAChR a1 on QPatch
31.03.2017
CFTR channels activated by flouride on QPatch
30.03.2017
CHO-hNav1.7 assay on Qube pharmacology, biophysical characterization and the effect of internal fluoride
30.03.2017
Cav1.2 on Qube 384
30.03.2017
TMEM16A on Qube